Key Takeaways
- Consolidated loss driven by accounting mismatch: Standalone Care Health posted strong Ind AS PBT of ₹163 crores, but the one-year forbearance on Ind AS 117 keeps that gain out of consolidated numbers, flipping the group to a loss.
- Care Health is the star, and it is sprinting: GWP grew 37% YoY, retail market share hit 12.6%, and the combined ratio improved 30 bps YoY to 102.6% despite a seasonally heavy corporate employee wellness book.
- The demerger hit a wall at RBI: The regulator has not acceded to the application, with no reasoning attached yet; management is engaging to understand the objection and remains committed to the route.
- Financial services are in deliberate rebuild mode: Broking PBT rebounded 53% YoY, but the lending entities are still dormant, with new CEOs hired and a restart targeted in about four months.
- What to watch next quarter: Whether RBI provides clarity on the demerger objection, the pace of RFL’s business restart, and Care Health’s combined ratio trajectory as it exits the corporate wellness-heavy Q1.
The Demerger: RBI Rejection and Next Steps
- RBI has said no, without saying why: The communication conveyed that the request for approval has not been acceded to, but the letter is brief with no reasoning attached, so the specific concern remains unknown.
- Engagement is the only plan right now: Management is engaging with the regulator to answer any questions and figure out the reason; it is not evaluating alternative structures, including a Care demerger, at this point.
- A new IRDAI guideline adds a wrinkle: A guideline on the collapse of a non-insurer into an insurer has been issued, and management is evaluating it, though it has not changed the current demerger focus.
- Timeline is now open-ended: The tentative Q1 FY28 deadline is likely delayed, and management declined to give a new timeline, stating only that it will make its best effort.
Arjun Lamba: "We are engaging with the regulators in this matter to answer any questions that they may have. We remain committed to the cause of delivering stakeholder value via this route."
Care Health Insurance: Growth Engine Firing
- Retail is driving a land-grab moment: GWP grew 37% YoY, with retail growing at 45% and fresh business growing faster than renewals; management sees a post-GST-relaxation window to take share and intends to beat the market.
- Market share is climbing: Retail health market share reached 12.6% of the industry and 21.6% among SAHI players, while overall market share stood at 6.7% of the industry and 24% within SAHI.
- Growth is coming from deeper India: Tier 2 and Tier 3 geographies are the primary drivers, and the number of consumers is growing faster than average ticket size.
- Port-in share has dropped sharply: The percentage share of portability inflows has come down drastically from last year, reducing a source of adverse selection risk.
- Digital operations are near-total: 99.9% of policies are issued digitally, over 85% of cashless claims are processed within 30 minutes, and 67% of active retail customers are on the mobile app.
| Metric | Q1 FY27 | Context |
|---|---|---|
| GWP growth (YoY) | 37% | Retail at 45%; fresh faster than renewal |
| Combined ratio (Ind AS) | 102.6% | Improved 30 bps YoY; elevated by corporate wellness book |
| PBT (Ind AS, standalone) | ₹163 crores | Vs ₹102 crores in Q1 FY26 |
| Opex ratio | 31.2% | Improved 100 bps YoY |
| Solvency target | 1.7x | Plan to maintain via equity or sub-debt as needed |
Ajay Shah: "Last call, I had said very clearly that we want to become 100% in next two years, and we are sticking and committed to that."
The Accounting Mismatch: Why Consolidated PAT Is Negative
- Ind AS 117 forbearance creates a phantom loss: Care Health took a one-year regulatory forbearance to stabilize technology, so its Ind AS 117 impact is not reflected in consolidated accounts; standalone Care on Ind AS shows a ₹163 crore PBT, while the consolidated group shows a loss.
- This is a one-year timing issue: From next year, both standalone and consolidated Care will be on the same Ind AS basis, eliminating the mismatch.
- The 1/n basis loss is transitional: Care reported a ₹131 crore loss on the 1/n basis versus a ₹19 crore loss in the previous year corresponding quarter, because these are transition years under the new accounting framework.
Financial Services: Rebuilding from a Low Base
Broking: Profitability Rebound, Strategy Still Forming
- PBT jumped 53% YoY to ₹10 crores: The rebound was driven by operating leverage, with brokerage income up 13% and interest income up 28% on a 78% expansion in the client debit book.
- Revenue de-grew sequentially, and that is called temporary: The QoQ decline is attributed to business repair, an unsupportive market, and investment in a new technology platform and products; annual increments and natural attrition were smaller factors.
- The competitive strategy is not yet defined: Management declined to answer how broking will compete in a cluttered market, stating that clear direction on the model will emerge in about one or two quarters.
- Near-term focus is productivity, not client acquisition: Before aggressive acquisition, the priority is improving the technology platform, digital offerings, and expanding the product platform, with margin funding and third-party products as growth levers.
Lending: Dormant Books, New Leaders, Restart Ahead
- RFL’s loan book has been shrinking for years: Lending activities were under embargo historically, and with no new disbursements for six to seven years, the book dwindled while net worth stayed intact and cash sat on the balance sheet.
- New CEOs have just arrived: Srinivasan Karthik joined RFL from HDB about three months back, and Pavan Gupta joined as MD and CEO of Religare Housing as recently as one month ago, so business building is in its earliest stages.
- A restart is targeted within about four months: Karthik is building out the team and hiring, with growth expected to commence in the next quarter or two; cash is available and the platform is ready for whichever business line is chosen.
- Housing finance is getting ₹250 crores of fresh capital: The commitment is to build a granular portfolio backed by residential mortgage assets, focused on self-employed and informal segments in semi-urban markets.
- The ambition is a ₹10,000–15,000 crore book: With ₹1,500–2,000 crores of capital, management believes this scale is achievable; business teams are working on annual operating plans and will return with details.
Arjun Lamba: "So we do believe that with INR1,500 crores to INR2,000 crores of capital we have ambitions for about a INR10,000 crores, INR15,000 crores book size."
Capital and Leverage
- Warrant conversions are funding the build: As of August 2026, ₹618 crores of proceeds have been received out of the ₹1,500 crore total raise, with the remaining ₹881 crores available for appropriate infusion.
- Care Health raised capital on two fronts: ₹150 crores of equity via a rights issue in Q1, and ₹200 crores of sub-debt in August 2026 after Q1 capital markets were in turmoil.
- REL is committed to funding Care’s growth: Management stated unequivocally that whenever Care needs money, REL and Kedaara will step in, calling Care the star in the crown.
- Leverage is expected to decline to around 3.7x by year-end: Additional capital will be infused this year via a preferential raise.
- Care’s next raise will most likely be a rights issue: REL subscribes fully to its quota plus additional subscription in every rights issue, leading to a marginal uptick in its stake over time.
Arjun Lamba: "So from REL's perspective that whenever they need money, we are happy to fund because this is our growing business, this is the star in the crown in the Jewel currently and we will fund this and I mean there's no doubt about that from our end."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Care Health combined ratio | Become 100% | Within two years |
| Care Health solvency | Maintain at 1.7x | Ongoing; equity or sub-debt as needed, with INR200 crores sub-debt already raised in August 2026 |
| RFL business restart | Commence lending growth | About four months |
| Housing finance capital infusion | ₹250 crores deployed to build granular mortgage book | Over the next few years |
| Broking model clarity | Clear direction on competitive model | In about one or two quarters, currently focused on repairing and productivity gains |
| Legacy NPA write-off recoveries | Focused team pursuing recoveries; book is dwindling | Bulk of recoveries likely in next two years |
| Leverage reduction | Decline to around 3.7x | By year-end FY27 |
Key Metrics
| Metric | Q1 FY27 |
|---|---|
| Consolidated revenue | ₹2,358 crores, +26% YoY |
| Consolidated PBT | Negative ₹76.73 crores, vs positive ₹5.73 crores in Q1 FY26 |
| Consolidated PAT | Negative ₹46.9 crores, mainly due to different reporting standards |
| Insurance segment revenue | ₹2,229 crores |
| Financial Services segment revenue | ₹133 crores |
| Care Health GWP growth | 37% YoY on full premium basis |
| Care Health retail business growth | 45% YoY on full premium basis |
| Care Health PBT (Ind AS) | ₹163 crores, vs ₹102 crores in Q1 FY26 |
| Care Health combined ratio (Ind AS) | 102.6%, improved 30 bps YoY |
| Care Health solvency ratio | 1.58x as of June 2026, vs regulatory requirement of 1.5x |
| Care Health market share (SAHI segment) | 24% |
| Care Health retail health market share (industry) | 12.6% |
| Broking total income | ₹99.5 crores, +7% YoY |
| Broking PBT | ₹10 crores, +53% YoY |
| Broking assets under custody | ₹47,946 crores as of June 30, 2026 |
| Broking average daily turnover (cash segment) | ₹375 crores, vs ₹334 crores in Q1 FY26 |
| RFL tangible net worth | ₹915 crores |
| RFL cash balance | Over ₹600 crores |
| RFL CRAR | 238% |
| RFL NNPA | Around 0.8% |
| RFL collection efficiency | 98% |
| RHDFCL AUM | ₹247 crores |
| RHDFCL GNPA | 4.4% |
| RHDFCL NNPA | 3.3% |
| RHDFCL capital adequacy | Over 121% |